Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
about
Mycophenolate mofetil enhances the negative effects of sirolimus and tacrolimus on rat kidney cell metabolismNew tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeuticsCellular and molecular targeting for nanotherapeutics in transplantation tolerance.Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized studyCelecoxib reduces the effects of acute and chronic UVB exposure in mice treated with therapeutically relevant immunosuppressive drugs.
P2860
Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
@en
Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
@nl
type
label
Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
@en
Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
@nl
prefLabel
Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
@en
Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
@nl
P1476
Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival
@en
P2093
Stepkowski SM
P304
P407
P577
1991-12-01T00:00:00Z